Sidoti Downgrades SurModics (SRDX) to Neutral
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
Sidoti earlier downgraded SurModics (NASDAQ: SRDX) from Buy to Neutral with a price target of $33 (unchanged).
Shares of SurModics closed at $30.42 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- H.C. Wainwright Downgrades Vertex (VRTX) to Neutral
- SunTrust Downgrades Syntel, Inc. (SYNT) to Hold
- Mizuho Securities Downgrades Teva Pharma (TEVA) to Neutral
Create E-mail Alert Related CategoriesDowngrades
Related EntitiesSidoti & Company
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!